It is attractive to speculate that re-activating COX-2 expression in advanced stages of cancer by modulating PACER expression would increase COX-2-mediated local tissue mobilization and inflammation, consequently leading to more efficient tumor clearing by immune cells. The gene discussed is PTGS2; the disease is neoplasm.